ng-nitroarginine methyl ester has been researched along with Bladder Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashikari, A; Kimura, R; Miyazato, M; Oshiro, T; Saito, S | 1 |
| Imazumi, K; Masuda, N; Noguchi, Y; Ohtake, A; Sakamoto, K; Takeda, M; Ueshima, K | 1 |
| Aikawa, K; Chichester, P; Levin, RM; Whitbeck, C | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Bladder Diseases
| Article | Year |
|---|---|
Age-associated urethral dysfunction in urethane-anesthetized rats.
Topics: Age Factors; Aging; Anesthetics, Intravenous; Animals; Enzyme Inhibitors; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Urethane; Urethra; Urinary Bladder Diseases; Urination | 2018 |
ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction.
Topics: Animals; Female; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Lysophosphatidic Acid; Tamsulosin; Urethra; Urinary Bladder; Urinary Bladder Diseases; Urine | 2019 |
Effect of nitric oxide synthase inhibition on changes induced by estradiol in bladders from ovariectomized rabbits.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Cystoscopy; Disease Models, Animal; Estradiol; Female; Immunohistochemistry; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ovariectomy; Probability; Rabbits; Random Allocation; Reference Values; Regional Blood Flow; Risk Factors; Sensitivity and Specificity; Urinary Bladder; Urinary Bladder Diseases; Vascular Resistance | 2005 |